Literature DB >> 10852238

Hypocretin/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons.

A Ivanov1, G Aston-Jones.   

Abstract

Recent studies demonstrated that noradrenergic locus coeruleus (LC) neurons are a particularly strong target of the novel neuropeptide, hypocretin (orexin). The present study sought to elucidate the action of hypocretin-B (HCRT) on LC neurons recorded intracellularly in rat brain slices. Bath (1.0 microM) or local puff application (50-100 microM in pipette) of HCRT depolarized LC neurons in rat brain slices and increased their spontaneous discharge rate. Depolarization evoked by HCRT was persistent in the presence of tetrodotoxin (TTX, 1 microM) and Co2+ (1 mM), indicating that HCRT directly activated LC neurons, and that its effect on the postsynaptic cell was not due to activation of TTX-sensitive sodium channels or Co2+-sensitive calcium channels. The apparent input resistance was significantly increased in the majority of LC neurons during the HCRT-evoked depolarization. Moreover, the HCRT-evoked depolarization was decreased in amplitude with hyperpolarization of membrane. The present results indicate that decreased potassium conductance is involved in the effect of HCRT on LC neurons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852238     DOI: 10.1097/00001756-200006050-00031

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  50 in total

1.  Neuronal Networks in Hypertension: Recent Advances.

Authors:  Patrice G Guyenet; Ruth L Stornetta; George M P R Souza; Stephen B G Abbott; Virginia L Brooks
Journal:  Hypertension       Date:  2020-06-29       Impact factor: 10.190

2.  Release of hypocretin (orexin) during waking and sleep states.

Authors:  Lyudmila I Kiyashchenko; Boris Y Mileykovskiy; Nigel Maidment; Hoa A Lam; Ming-Fung Wu; Joshi John; John Peever; Jerome M Siegel
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

3.  Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons.

Authors:  Laurence Bayer; Mauro Serafin; Emmanuel Eggermann; Benoît Saint-Mleux; Danièle Machard; Barbara E Jones; Michel Mühlethaler
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

Review 4.  Energy expenditure: role of orexin.

Authors:  Jennifer A Teske; Vijayakumar Mavanji
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

5.  The orexin system regulates alcohol-seeking in rats.

Authors:  Andrew J Lawrence; Michael S Cowen; Hong-Ju Yang; Feng Chen; Brian Oldfield
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 6.  Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity.

Authors:  Angie M Cason; Rachel J Smith; Pouya Tahsili-Fahadan; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Physiol Behav       Date:  2010-03-23

Review 7.  Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.

Authors:  George F Koob; Ian M Colrain
Journal:  Neuropsychopharmacology       Date:  2019-06-24       Impact factor: 7.853

8.  Dual orexin actions on dorsal raphe and laterodorsal tegmentum neurons: noisy cation current activation and selective enhancement of Ca2+ transients mediated by L-type calcium channels.

Authors:  K A Kohlmeier; S Watanabe; C J Tyler; S Burlet; C S Leonard
Journal:  J Neurophysiol       Date:  2008-07-30       Impact factor: 2.714

9.  Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons.

Authors:  Laurence Bayer; Emmanuel Eggermann; Benoît Saint-Mleux; Danièle Machard; Barbara E Jones; Michel Mühlethaler; Mauro Serafin
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

Review 10.  Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia.

Authors:  Y Chudasama; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2004-04-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.